Saad, Ahmed <br/><br/>
Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients With Atherosclerotic Renal Artery Stenosis.  [electronic resource] 

 -  Circulation. Cardiovascular interventions  Sep 2017 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1941-7632 
<br/><br/><label>Standard No.: </label>10.1161/CIRCINTERVENTIONS.117.005487  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angioplasty, Balloon--adverse effects<br/>Antioxidants--administration & dosage<br/>Atherosclerosis--blood<br/>Computed Tomography Angiography<br/>Double-Blind Method<br/>Female<br/>Glomerular Filtration Rate--drug effects<br/>Humans<br/>Hypoxia--blood<br/>Infusions, Intravenous<br/>Kidney--drug effects<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Mitochondria--drug effects<br/>Multidetector Computed Tomography<br/>Oligopeptides--administration & dosage<br/>Oxidative Stress--drug effects<br/>Perfusion Imaging--methods<br/>Pilot Projects<br/>Recovery of Function<br/>Renal Artery Obstruction--blood<br/>Renal Circulation--drug effects<br/>Reperfusion Injury--blood<br/>Risk Factors<br/>Stents<br/>Time Factors<br/>Treatment Outcome